Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

608 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 608 results

Testing effectiveness (Phase 2)Study completedNCT00139360
What this trial is testing

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Haukeland University Hospital 35
Not applicableStudy completedNCT03752060
What this trial is testing

The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women

Who this might be right for
Cardiovascular Risk FactorMenopause Related ConditionsNeuromuscular Function+2 more
Oklahoma State University 68
Not applicableUnknownNCT00475202
What this trial is testing

Hyperbaric Oxygen Therapy and Angiogenesis in Diabetic Patients With Foot Ulcers

Who this might be right for
Diabetic Foot UlcersHyperbaric TherapyAngiogenesis
Assaf-Harofeh Medical Center
Early research (Phase 1)Ended earlyNCT00704821
What this trial is testing

PTC299 for Treatment of Advanced Cancer

Who this might be right for
Advanced Cancer
PTC Therapeutics 76
Not applicableStudy completedNCT03439332
What this trial is testing

Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma

Who this might be right for
Glioblastoma
Juan M Garcia-Gomez 305
Testing effectiveness (Phase 2)Study completedNCT01705184
What this trial is testing

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Intergroupe Francophone de Cancerologie Thoracique 120
Early research (Phase 1)Study completedNCT00005647
What this trial is testing

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 12
Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Testing effectiveness (Phase 2)Study completedNCT01391962
What this trial is testing

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

Who this might be right for
Sarcoma, Alveolar Soft Part
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)Study completedNCT01668784
What this trial is testing

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Who this might be right for
Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
Bristol-Myers Squibb 821
Early research (Phase 1)Study completedNCT00619424
What this trial is testing

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 58
Large-scale testing (Phase 3)Study completedNCT00532155
What this trial is testing

Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
CarcinomaNon Small Cell Lung
Sanofi 913
Testing effectiveness (Phase 2)Ended earlyNCT01120158
What this trial is testing

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 46
Early research (Phase 1)Ended earlyNCT02666547
What this trial is testing

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Who this might be right for
Pathological Angiogenesis
University of Lausanne Hospitals 42
Testing effectiveness (Phase 2)Study completedNCT03013335
What this trial is testing

Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen

Who this might be right for
Metastatic Renal Cell Carcinoma
UNICANCER 730
Testing effectiveness (Phase 2)Looking for participantsNCT04941274
What this trial is testing

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 86
Early research (Phase 1)Study completedNCT00659555
What this trial is testing

Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops

Who this might be right for
Macular Degeneration
GlaxoSmithKline 24
Not applicableUnknownNCT03757507
What this trial is testing

Investigation of Plaque Instability Using Bevacizumab-800CW and MSOT

Who this might be right for
AtherosclerosisCarotid StenosisFluorescence
G.M. van Dam 15
Not applicableUnknownNCT03376191
What this trial is testing

Apatinib in Advanced Non-squamous，NSCLC

Who this might be right for
Non-squamous Non-Small Cell Lung Cancer
Jian Fang 100
Not applicableUnknownNCT00262093
What this trial is testing

Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence

Who this might be right for
Pre-Eclampsia
Hadassah Medical Organization 200
Load More Results